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https://doi.org/10.1016/j.stemcr.2020.08.003SUMMARYThe ability of human induced pluripotent stem cells (hiPSCs) to differentiate in vitro to each of the three germ layer lineages has made
them an important model of early human development and a tool for tissue engineering. However, the factors that disturb the intricate
transcriptional choreography of differentiation remain incompletely understood. Here, we uncover a critical time window during which
DNA damage significantly reduces the efficiency and fidelity with which hiPSCs differentiate to definitive endoderm. DNA damage pre-
vents the normal reduction of p53 levels as cells pass through the epithelial-to-mesenchymal transition, diverting the transcriptional pro-
gram towardmesodermwithout induction of an apoptotic response. In contrast,TP53-deficient cells differentiate to endodermwith high
efficiency afterDNAdamage, suggesting that p53 enforces a ‘‘differentiation checkpoint’’ in early endodermdifferentiation that alters cell
fate in response to DNA damage.INTRODUCTION
In vitro differentiation of human induced pluripotent stem
cells (hiPSCs) and embryonic stem cells (hESCs) to defini-
tive endoderm (DE) is induced by activation of the Acti-
vin/Nodal, FGF, BMP4, and WNT signaling pathways in
concert with inhibition of phosphoinositide 3-kinases
(Vallier et al., 2009). Downregulation of the core pluripo-
tency transcription factors SOX2, NANOG, and POU5F1 in-
creases expression of EOMES (Teo et al., 2011), which drives
a transition through a primitive streak-like stage (Arnold
et al., 2008). The cells then undergo the epithelial-to-
mesenchymal transition (EMT) and acquire markers of
DE, including SOX17 (Kanai-Azuma et al., 2002) and
FOXA2 (Dufort et al., 1998).
p53 is central to the cellular response to DNA damage
(Williams and Schumacher, 2016). In somatic cells, p53 is
maintained at a low level through degradation induced
by the E3 ubiquitin ligase MDM2 (Michael and Oren,
2003). In response to DNA damage, a well-described
signaling cascade leads to ATM-dependent phosphoryla-
tion of p53 and its stabilization (Banin et al., 1998; Can-
man et al., 1998). Activated p53 then drives a transcrip-
tional program leading to cell-cycle arrest to facilitate
DNA repair and, if unsuccessful, senescence or apoptosis
(Shiloh and Ziv, 2013).
Inmouse embryonic stem cells p53 activation can lead to
differentiation through suppression of the pluripotency
factor Nanog (Lin et al., 2005) and modulation of WNT
signaling (Lee et al., 2010). This leads to damaged cells be-
ing removed from the stem cell pool, limiting their capacityStem Cell Reports j Vol. 15 j 1
This is an open access artito propagate genetic defects (Lin et al., 2005). Nonetheless,
Trp53-null mice largely develop normally (Donehower
et al., 1992), although female mice are highly susceptible
to exencephaly (Armstrong et al., 1995; Sah et al., 1995).
In contrast, inXenopus embryos depleted of p53,mesoderm
differentiation is inhibited (Cordenonsi et al., 2003) and
gastrulation is not completed (Wallingford et al., 1997).
These differences may be explained at least in part by the
availability of other p53 family members in mammalian
cells, p63 and p73, which together with p53 are important
for coordination of signaling pathways controlling mesen-
doderm differentiation (Wang et al., 2017) by inducing
expression of genes, including members of the Wnt and
Fzd families (Lee et al., 2010). WNT activates TCF3, which,
with SMAD2/3, binds to enhancers of mesendoderm genes
and activates their transcription (Wang et al., 2017).
Elevated p53 levels in the early embryo decline signifi-
cantly during embryonic development (Schmid et al.,
1991). Mice lacking one of the p53 regulators Mdm2 or
Mdm4 do not survive embryonic development, and this
can be rescued by concurrent disruption of Trp53 (Jones
et al., 1995; Montes de Oca Luna et al., 1995; Parant
et al., 2001). Conversely, overexpression of Trp53 perturbs
renal differentiation, further suggesting that tight control
of p53 is required for successful development (Godley
et al., 1996). Despite this work on the roles of p53 in
both differentiation and the response of stem cells to
DNA damage, surprisingly little is known about the p53-
dependent response to DNA damage in a differentiating
stem cell. Here we address this question using an iPSC
model of human endoderm differentiation.–9 j October 13, 2020 j ª 2020 MRC Laboratory of Molecular Biology. 1
cle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. DNA Damage Inhibits Endoderm
Differentiation in hiPSCs
(A) Highly simplified genetic circuit con-
trolling differentiation to DE.
(B) Scheme for in vitro endoderm differenti-
ation over 72 h.
(C) Permeabilized flow cytometry to monitor
expression of EOMES (center) and SOX17
(right) during differentiation to DE. DNA
content (DAPI, left) shows the change in the
cell-cycle profile during differentiation, with
a marked shift toward G1.
(D) Kinetics of EOMES and SOX17 expression
during DE differentiation (n = 4 indpendent
experiments, mean ± SEM is plotted).
(E) Inhibition of DE differentiation by expo-
sure to MMS throughout differentiation. MMS
(5 ppm) was administered at 0, 24, and 48 h
(n = 8 independent experiments, ****p <
0.0001 using a paired t test, mean ± SEM is
plotted).
(F) Inhibition of DE differentiation by expo-
sure to a single dose of 5 ppm MMS at 24 h
(n = 12 independent experiments, ****p <
0.0001 using a paired t test, mean ± SEM is
plotted).
(G) Dose-dependent inhibition of DE differ-
entiation by MMS treatment at 24 h (n = 5
independent experiments, mean ± SEM is
plotted).
(H) Cells were treated with 5 ppm MMS every
6 h during differentiation and the efficiency
of differentiation at 72 h was monitored (nR
2 independent experiments for each time
point, mean ± SEM is plotted).
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DNA Damage Decreases the Efficiency of hiPSC
Differentiation to DE
We employed the BOBSC hiPSC line (Andersson-Rolf et al.,
2017), a derivative of cA1ATD (Yusa et al., 2011), and an es-
tablished protocol for driving DE differentiation over 72 h
(Yiangou et al., 2019) (Figures 1A and 1B). Differentiation
was initially monitored using flow cytometry on permeabi-
lized cells with antibodies against the mesendoderm
marker EOMES and against SOX17, which marks DE (Ar-
nold et al., 2008; Kanai-Azuma et al., 2002). The proportion
of cells expressing SOX17 at 72 h thus provides a simple
assay to monitor the efficiency of differentiation (Figures
1C and 1D). Detection of SOX17 by flow cytometry closely
mirrored changes in mRNA levels during differentiation
(Figure S1A).
To assess the impact of DNA damage on endoderm differ-
entiation, we treated cells with 5 ppmmethyl methanesul-
fonate (MMS) at 0, 24, and 48 h after initiating differentia-2 Stem Cell Reports j Vol. 15 j 1–9 j October 13, 2020tion (Figure 1B). MMS generates 7-methylguanine and
3-methyladenine in DNA (Beranek, 1990), which can lead
to replication stalling and DNA damage (Lundin et al.,
2005). It has a half-life of about 4.5 h in aqueous solution
(PubChem: CID 4156 https://pubchem.ncbi.nlm.nih.-
gov/compound/4156). MMS treatment resulted in a signif-
icant reduction in SOX17-expressing cells at 72 h (Fig-
ure 1E). A single dose of MMS at 24 h (Figure 1B) had a
similar effect (Figure 1F) and did not alter the number of
cell divisions (Figure S1B) or cell viability (Figure S1C). Like-
wise, a single low dose of UV-C (2 J/m2) at 24 h reduced the
proportion of SOX17-expressing cells at 72 h (Figure S1D).
Furthermore, the decrease in efficiency of differentiation
was proportional to the dose of MMS (Figure 1G) and UV
(Figure S1E). Importantly, the reduction in SOX17-positive
cells at 72 h following damage was not simply the result of
differentiation delay, as continuing to 96 h did not increase
the proportion of cells expressing SOX17 (Figure S1F).
In order to ensure that the damage-induced decrease in
the efficiency of differentiation was not a specific feature
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Figure 2. DNA Damage during Early Endoderm Differentiation
Prevents Reduction of p53 Levels
Western blot analyses of changes to the DNA-damage response
during differentiation, with and without 5 ppm MMS treatment at
24 h. Protein was collected from whole-cell lysates every 12 h.
Positive control samples were collected for protein 5 h after
treatment, including 2 mM HU and 20 J/m2 UV-C.
(A) Phospho-CHK1 (Ser-345) and total CHK1, with PCNA as a
loading control.
(B) Phosphorylation of RPA32 (Ser-33), total RPA, phosphorylation
of CHK2 (Thr-68), total CHK2, and b-ACTIN as a loading control.
(C) Phospho-H2AX (Ser-139), total MDM2, phospho-p53 (Ser-15),
and total p53. PCNA is used as a loading control.
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the H9 hESC line (Thomson et al., 1998), which had a dif-
ferentiation efficiency similar to that of BOBSC (Fig-
ure S1G). Treatment with both MMS and UV irradiation
at 24 h likewise significantly decreased the number of cells
expressing SOX17 at 72 h (Figures S1H and S1I), confirm-
ing that the effect of DNA damage on differentiation is
likely to be generalizable.
We next determined the effect of DNA damage on dif-
ferentiation efficiency as a function of time of exposure
during the protocol. A single dose of 5 ppm MMS was
administered at different times during the differentiation
protocol and the proportion of cells expressing SOX17 at
72 h measured (Figure 1H). MMS had a maximal inhibi-
tory effect on differentiation when administered in a
window between ~20 and 34 h. Treatment after 40 h
had very little effect on the outcome of differentiation,
when a proportion of cells had begun expressing
SOX17. This suggested that once the cells have
committed to DE, the outcome cannot be altered by
DNA damage.
A Fall in p53 Level during Early Endoderm
Differentiation Is Prevented by DNA Damage
To understand the role of DNA-damage-response (DDR)
pathways throughout differentiation, we monitored key
features of the DDR by western blotting (Figure 2). The to-
tal levels of key DDR kinases CHK1 and CHK2, as well as
one of their substrates, RPA, did not change during the
differentiation protocol (Figures 2A and 2B). However,
p53 levels fell as differentiation proceeded (Figure 2C),
but were increased following treatment with 5 ppm
MMS at 24 h (Figure 2C). Interestingly, while the low
dose of MMS used in these experiments stabilized p53
and induced MDM2 expression, it was accompanied by
minimal or no phosphorylation of the DNA-damage
markers CHK1, CHK2, and RPA; H2AX; or p53 itself. A
somewhat surprising observation in this context was a
spike of phosphorylation of the histone variant H2AX
around 50 h into differentiation (Figure S2). Phosphory-
lated H2AX (gH2AX) is frequently used as a surrogate
marker for DNA double-strand breaks (Rogakou et al.,
1998) and was therefore unexpected during normal differ-
entiation. The observed spike of gH2AX was not induced
by exogenous DNA damage; indeed, it was attenuated
by it (Figure 2C) and was also not accompanied by signif-
icant DNA-damage signaling (Figure 2). We speculate
that it may be related to the EMT through which the cells
pass at this time (Teo et al., 2011). Indeed, H2AX phos-
phorylation during the EMT in cancer cell line models
has previously been shown to play a role in transcriptional
regulation of the vast gene expression changes that
occur (Singh et al., 2015).Stem Cell Reports j Vol. 15 j 1–9 j October 13, 2020 3
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Figure 3. Loss of TP53 Rescues DE Differentiation after DNA
Damage
(A) The percentage of cells expressing SOX17 at 72 h of differen-
tiation in the wild-type (WT) and TP53/ cell line. No difference in
the efficiency of differentiation was seen between the two cell lines
using an unpaired t test (p = 0.8126, n = 6 independent experi-
ments, mean ± SEM is plotted).
(B) WT and TP53/ cell lines were treated with 5 ppmMMS at 0, 24,
and 48 h into differentiation (when the medium was changed), and
efficiency of treated cells was expressed as a percentage of un-
4 Stem Cell Reports j Vol. 15 j 1–9 j October 13, 2020
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Damage
To explore whether the DNA-damage-induced stabiliza-
tion of p53 was linked to the failure to acquire markers
of DE, we differentiated a TP53/ BOBSC cell line (see
Supplemental Experimental Procedures and Figure S3A)
with and without exposure to MMS. The untreated
TP53/ and wild-type cells differentiated with the same
efficiency (Figure 3A). However, TP53/ cells differenti-
ated with a much higher efficiency than the wild-type
cell line when treated with MMS during differentiation
(Figure 3B), while exhibiting a similar G2/M cell-cycle
block (Figure 3C). It is noteworthy that although loss of
p53 reduces the fraction of cells in G1 during MMS expo-
sure, consistent with the known role of p53 in the G1/S
checkpoint (Smith et al., 2020), the predominant accumu-
lation of cells is in G2/M in both wild-type and, to a
greater extent, TP53/ cells (Figure 3C). This likely re-
flects both the chronic, low-dose DNA damage used in
these experiments and the significant reliance on S-phase
recombination pathways for tolerating the replication-
stalling lesions created by MMS (Lundin et al., 2005).
Disruption of TP53 also rescued differentiation when
MMS and UV were administered at 24 h only (Figures
S3B and S3C). The restoration of efficient differentiation
in MMS-treated TP53/ cells was not explained by a
change in the number of cell divisions (Figure S3D) and
occurred despite similar levels of MMS-induced DNA dam-
age detectable in alkaline comets, compared with wild-
type cells (Figures 3D and 3E). Thus, the loss of p53 is suf-
ficient to apparently rescue DE differentiation in the face
of DNA damage.
To understand the nature of the p53-dependent changes
in the DE transcriptional program induced by DNA dam-
age, we performed time-resolved RNA sequencing during
endoderm differentiation and in undifferentiated cells,treated cells. Significance was calculated using an unpaired t test
(****p < 0.0001, n = 6 independent experiments, mean ± SEM is
plotted).
(C) WT and TP53/ cells were differentiated either without
treatment or with exposure to 5 ppm MMS at 0, 24, and 48 h. Cells
were collected at 72 h and monitored for SOX17 expression and cell-
cycle phase using DAPI. The SOX17-positive proportion of cells and
the proportion of cells in each phase of the cell cycle are shown.
Cell-cycle quantification was calculated using the Dean-Jett-Fox
model on FlowJo.
(D) Alkaline comet analysis was performed on WT and TP53/
differentiating cells. Cells were treated with or without 5 ppm MMS
at 24 h and collected 2 h later for analysis (n = 2 independent
experiments with >400 comets analyzed per condition; p values
calculated with Kruskal-Wallis with Dunn’s multiple comparisons
test, ****p < 0.0001).
(E) As for (D) but showing tail moment, ****p < 0.0001.
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Figure 4. DNA-Damage-Induced Activation of p53 Enforces a Damage-Induced Transcriptional Program that Drives Differentiation
toward Mesoderm
(A) Schematic to show the workflow of the experimental setup for RNA sequencing. On day1 WT and TP53/ cells were passaged, and on
day 0 the experiment was initiated. Undifferentiated cells were cultured, in parallel to the differentiating cells, in Essential 8 Flex (E8flex)
medium. RNA was extracted from both cell lines in the undifferentiated state and during differentiation every 24 h (days 1, 2, 3). In
parallel, cells were treated with 5 ppm MMS at 24 h and RNA was extracted at days 2 and 3.
(B) Gene expression changes during differentiation: differentially expressed genes between untreated WT cells undergoing differentiation
and undifferentiated cells collected at 24 h are shown. The overlap between the differences is shown at 24, 48, and 72 h of differentiation.
(C) Comparison of the differentially expressed genes after MMS treatment compared with untreated cells in the wild-type cell line: during
differentiation (left) and undifferentiated cells (right). The top shows 48 h (24 h after treatment) and the bottom 72 h (48 h after
treatment).
(D) Comparison of both WT and TP53/ with and without MMS treatment during differentiation. The difference between treated and
untreated cells at 48 h (top) and 72 h (bottom) is shown.
(E) A Venn diagram to show the overlap of the list of p53-response genes (Fischer, 2017) with those altered during differentiation after
MMS treatment.
(F) Heatmap to show the expression of different lineage-specific markers and pluripotency markers at 72 h of differentiation in both WT
and TP53/ cell lines, with and without MMS treatment at 24 h.
(legend continued on next page)
Stem Cell Reports j Vol. 15 j 1–9 j October 13, 2020 5
Please cite this article in press as: Eldridge et al., A p53-Dependent Checkpoint Induced upon DNA Damage Alters Cell Fate during hiPSC
Differentiation, Stem Cell Reports (2020), https://doi.org/10.1016/j.stemcr.2020.08.003
Please cite this article in press as: Eldridge et al., A p53-Dependent Checkpoint Induced upon DNA Damage Alters Cell Fate during hiPSC
Differentiation, Stem Cell Reports (2020), https://doi.org/10.1016/j.stemcr.2020.08.003with and without exposure to 5 ppmMMS at 24 h, in both
wild-type and TP53/ cells (Figure 4A).
DNA-Damage-Induced p53 Enforces a Transcriptional
Program thatDrivesDifferentiation towardMesoderm
As expected, vast changes in gene expression accompanied
endoderm differentiation (Figure 4B and Table S1). Treat-
ment with MMS imposed significant additional changes
on gene expression in the cells undergoing endoderm dif-
ferentiation but had much less effect on undifferentiated
cells (Figure 4C). The vast majority of the changes induced
by MMS during differentiation were dependent on p53
(Figure 4D). Interestingly, while known p53 targets were
transcriptionally upregulated 24 h after exposure to
MMS in differentiating cells (Figure S4), only a small per-
centage of the genes affected are described as robust p53
targets (Figure 4E). This may reflect the strong bias in so-
matic cell p53 targets in the published literature (Fischer,
2017). Nonetheless, KEGG pathway analysis identifies
p53 signaling as the most significantly affected pathway
at this time (Table S2). Gene ontology (GO) analysis of
the genes differentially expressed at 48 h into differentia-
tion between wild-type treated and untreated cells re-
vealed the most significant terms to be development,
morphogenesis, and differentiation (Table S3). This sug-
gests that MMS treatment was specifically affecting differ-
entiation-related pathways. Inclusion of terms involving
nervous system development also suggested that MMS
treatment may alter lineage specification. At 72 h the sig-
nificance of the developmental and morphogenesis terms
was even more marked (Table S3). The number of genes
significantly deregulated by MMS in the TP53/ cell line
was low (Figure 4D), and thus the GO analysis revealed
no significant terms at 48 h, while those that reached sig-
nificance at 72 h (Table S3) were involved in ion transport,
which has previously been linked to p53 function (Mak
et al., 2017).
To explore whether DNA damage does indeed redirect
differentiation in a p53-dependent manner, we exam-
ined changes in expression in key pluripotency and
lineage-specific markers (Saili et al., 2019) in each
condition (Figure 4F). MMS-treated wild-type cells ex-
pressed lower levels of DE markers and higher levels of
most mesoderm markers, along with small changes in
ectoderm markers. This effect was almost exclusively
dependent on p53, demonstrating that the DNA-dam-
age-induced activation of p53 during a critical window
of DE specification in hiPSCs alters the trajectory of
differentiation.(G) A model to suggest how DNA damage induces p53 stabilization and
outcome of differentiation. The upregulation of p53 in this context cau
the trajectory of differentiation.
6 Stem Cell Reports j Vol. 15 j 1–9 j October 13, 2020DISCUSSION
Our observation that exposure to a low dose of a DNA-
damaging agent during a critical window in the differenti-
ation of hiPSCs to DE disturbs the efficiency and fidelity of
the differentiation program is consistent with a recent
study showing that overproduction of endogenous reactive
oxygen species perturbs endoderm differentiation in
hiPSCs, reducing SOX17 expression and creating cells
with tumorigenic potential in nude mice (Oka et al.,
2020). Our study shows that the DNA-damage-induced
redirection of differentiation is entirely dependent on the
upregulation of p53. This p53-dependent response occurs
without significant purging of damaged cells, suggesting
that differentiating hiPSCs lack the ‘‘safety net’’ of an
apoptotic response, highlighting the potential risk of
damaged and transcriptionally perturbed cells remaining
in the population.
Although Trp53 is dispensable for broadly normal devel-
opment in the mouse (Donehower et al., 1992), the Trp53
family, which includes Trp63 and Trp73, has been pro-
posed to act redundantly to initiate mesendoderm differ-
entiation by direct transcriptional regulation (Wang
et al., 2017). Interestingly, neither TP63 nor TP73 was ex-
pressed (Table S4), suggesting that theywere unlikely to be
substituting for TP53 in our system. Our observations sug-
gest that the downregulation of p53 during DE differenti-
ation may be necessary to allow the normal transcrip-
tional program to proceed. This is consistent with
previous work showing that while p53 is necessary for
cells to initiate the EMT, attenuation of its levels by
MDM2 is necessary to allow expression of the mesen-
chymal phenotype (Araki et al., 2010; Chang et al.,
2011). Indeed, downregulation of p53 may be directly
controlled by this transition, as the EMT factor TWIST1
is able to bind to p53, leading toMDM2-dependent degra-
dation (Piccinin et al., 2012). We suggest that unsched-
uled stabilization of p53, caused by DNA damage during
the EMT, results in a transcriptional perturbation driving
differentiation away from DE (Figure 4G). Although the
apical transcriptional targets of p53 upregulation in this
context remain to be defined, we speculate that the effect
could be, at least in part, mediated by extendedWNT/BMP
signaling (Gertow et al., 2013; Kempf et al., 2016; Lindsley
et al., 2006).
It will be important to determine if the effect of p53
stabilization on differentiation after DNA damage that
we observe in the lines studied here is generalizable
to all human stem cells. However, if p53-dependentthis leads to a change in gene expression in these cells, altering the
ses upregulation of mesoderm-lineage-specific genes, thus altering
Please cite this article in press as: Eldridge et al., A p53-Dependent Checkpoint Induced upon DNA Damage Alters Cell Fate during hiPSC
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low doses of DNA damage also occurs during human em-
bryonic development, it may provide a mechanism by
which damaged cells could be diverted away from forming
germ cells, which are formed from the endodermal lineage.
More extensive damage may well lead to increased
apoptosis, as has been observed in irradiated mouse em-
bryos (Heyer et al., 2000), and to a disordered embryo
that would likely be lost before birth.EXPERIMENTAL PROCEDURES
hiPSC and hESC Culture
Cells were cultured at 37C, 5% CO2 in Essential 8 or Essential 8
Flexmediumon6well plates coated inVitronectin-XF (STEMCELL
Technologies). Cells were passaged 1:10 every 3–4 days depending
on confluency. Cells were detached from the plates by a wash in
1mL of 0.5 mM EDTA (Thermo Fisher Scientific) followed by incu-
bation in fresh EDTA for 5 min before the EDTA was removed and
the cells were blasted with medium to detach them. Cells were
maintained as small clumps. Endoderm differentiation was driven
as described (Yiangou et al., 2019) (Figure 1B, with full details in
Supplemental Experimental Procedures).MMS Treatment/UV-C Irradiation
MMS (Sigma) was freshly diluted 1000-fold in cell medium and
vortexed before being added to cells at the final concentration.
UV-C was delivered in a custom-built shuttered cabinet with a sta-
bilized bulb output measured with a calibrated UV-C meter (UVP,
Inc). Prior to irradiation, cell mediumwas replaced with 1 mL PBS.Cell Division and Cell Death Assays
Cell division was monitored with a CellTrace Violet cell prolifera-
tion kit (Invitrogen). Cell deathwas determined using the FITCAn-
nexin V apoptosis detection kit with 7-AAD (Biolegend). Full de-
tails of both procedures are provided in the Supplemental
Experimental Procedures.Flow Cytometry
For intracellular staining, ca. 1 3 106 cells were collected, having
been detached from the plate with 1 mL Cell Dissociation Buffer
(Thermo Fisher Scientific) for 10 min at 37C. Following centrifu-
gation in a 1.5 mL tube (1,5003 g, 4 min), the cell pellet was fixed
in 200 mL 1% paraformaldehyde for 10 min at room temperature,
repelleted, and resuspended in 200 mL of 90% PBS/10% DMSO
and kept at 80C until preparation for flow cytometry.
Fixed cells were thawed at room temperature for 10min, pelleted
(1,500 3 g, 4 min), and resuspended in 200 mL 13 BD Perm/Wash
buffer. Samples were divided in two to provide an IgG control, pel-
leted, and resuspended in 100 mL BD buffer. Cells were permeabi-
lized and blocked (15 min, room temperature) and spun down
for antibody staining: either primary followed by secondary or
conjugated antibody staining. For antibodies used see Supple-
mental Experimental Procedures.Protein Extraction, SDS-PAGE, and Western Blotting
Cells from a single well of a 6 well plate were harvested as described
for flow cytometry and proteinwas extracted using RIPA buffer and
standardmethods. Full details and antibodies used are given in the
Supplemental Experimental Procedures.
Alkaline Comet Assay
The R&D Systems comet assay kit was used according to the man-
ufacturer’s instructions. Further details are in the Supplemental
Experimental Procedures. More than 100 comets were analyzed
for each replicate of each condition. The CometScore 2.0 software
(TriTek Corp.) was used to calculate the average tail moment.
RNA Extraction and Quantitative Reverse
Transcription PCR
RNA extraction was performed using the RNeasy Qiagen RNA
extraction kit and reverse transcribed with the Qiagen QuantiTect
reverse transcription kit, using 800 ng RNA. qPCR was performed
with SYBR Green Mastermix (Applied Biosystems) and a ViiA7
real-time qPCR system (Applied Biosystems). Full details are in
the Supplemental Experimental Procedures.
Library Preparation for RNA Sequencing and RNA-
Sequencing Data Analysis
RNA was extracted and libraries were prepared using standard
methods (detailed in Supplemental Experimental Procedures).
Raw sequencing data were trimmed for adaptor sequences with a
minimum quality threshold of 30 using TrimGalore v.0.4.4
(https://github.com/FelixKrueger/TrimGalore). Trimmed reads
were aligned to the human genome version GRCh38.87 using To-
pHat v.2.1.0 (Kim et al., 2013) and quantified per genomic region
and differential expression was calculated using Cufflinks v.2.2.1
(Trapnell et al., 2013). Gene lists for Venn diagrams were created
using the following cutoffs: fragments per kilobase of transcript
per million mapped reads (FPKM) R1 for both samples, log2 fold
changeminimumof 1, and significantly different expression taken
as calculated from CuffDiff (Trapnell et al., 2013). The Python li-
brary Matplotlib (Hunter, 2007) was used to produce Venn dia-
grams from lists of differentially expressed genes, and Seaborn
(https://doi.org/10.5281/zenodo.3629446) was used for gener-
ating heatmaps, plotting the mean FPKM per triplicate for each
condition.
Data and Code Availability
The RNA-sequencing data have been deposited in GEO (https://
www.ncbi.nlm.nih.gov/geo/) with accession no. GSE146225.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/
10.1016/j.stemcr.2020.08.003.
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